Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LumiMeds vs Sprout Health

LumiMeds
Graded #143

Lower grade

vs+17.80000000000001
Sprout Health
Graded #6

Higher grade

The verdict

Sprout Health takes it — 86.4/100 to 68.6/100.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSprout Health +13
77
90
Dose & formulationSprout Health +18
64
82
Clinical oversightSprout Health +6
82
88
Labs & monitoringSprout Health +39
53
92
FulfillmentSprout Health +13
65
78
Contract termsSprout Health +29
55
84
LumiMeds · left barSprout Health · right bar

The numbers

MetricLumiMedsSprout Health
WeighScore68.6/10086.4/100
GradeCB
Scorecard rank#143#6
Semaglutide$133/mo (starting dose, compounded)$149/mo
Tirzepatide$133/mo (starting dose, compounded)$199/mo
CoverageCoverage not publishedNot disclosed
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
LumiMeds

Graded #143 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Sprout Health

Graded #6 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard